- Consumer Products
- Latest 6.70
- Currency US$
- Change 0.40
- Percent Change 6.349 %
- Volume 4,003,493
- Fri Dec 20, 2013 04:00 PM EST NASDAQ data delayed 15 minutes.
12 months ended Sep 30, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Nov 7||$-0.19||Mar 11||$-0.23|
12 months ended Dec 21, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1ß with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.